- Poster presentation
- Open Access
Candida non albicans isolates with a high antibiotic resistance: a real threat for cancer patients in Karaj City
© Kalantar et al; licensee BioMed Central Ltd. 2015
- Published: 16 June 2015
- Cancer Patient
- Oral Cavity
- Oral Cancer
- Molecular Identification
- Multiplex Polymerase Chain Reaction
Cancer patients remain at substantial risk for developing serious infections particularly oropharyngeal Candidiasis. Because of a weakened line of defense in oral cancer patients, the present prospective study was carried out, with the aim of isolation, and identification of Candida spp from oral cavity of cancer patients.
From 50 cancer patients with oropharyngeal candidiasis sample was taken by the physician. All samples were sent to Research Laboratory, School of Medicine, Alborz University of Medical Sciences and processed by standard methods for Isolation and identification. Antifungal resistance pattern was carried out according to CLSI guideline.
By Multiplex Polymerase Chain Reaction, identification of the 18s Ribosomal RNA among Candida spp was performed using specific primers for the molecular identification of Candida spp.
Of the 50 patients which, 18 (36%) were female and 32 (64%) were male; mean ages was 38.4 years. Leukemia and lymphoma were the most frequent cancer in the studied group, accounting for 17 (34%) and 12 (24%) respectively. The mean weight of the patients was 73.2 Kg. A total of 29 Candida spp were isolated from 29 of cancer patients with oropharyngeal candidiasis; of which 17 were C. albicans and 12 were C. non – albicans.
All the Candida spp were confirmed using the 18s Ribosomal RNA specific primers for the molecular identification of Candida spp. Among all the Candida spp, Candida non – albicans showed a high resistance pattern to amphotricin B (MIC 07 µg / ml) and ketokenazole (MIC=05 µg / ml).
In conclusion, oropharyngeal Candidiasis is a serious infection among cancer patients. The isolated candida spp were resistant to common antifungal agents which may leads to longer hospital stay, more expensive/ toxic drugs and higher mortality. Therefore, interval surveillance is necessary in developing institutional guidelines.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.